GlassScriptPhysician profile
Julien E Dagenais
NPI 1649579228
$10,980.63
in general payments reported to CMS, 2019-2025
19 companies · $8,525 in 2025
The $8,525 reported for 2025 was more than what 93% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $984 · 2020: $256 · 2021: $22.76 · 2022: $552 · 2023: $398 · 2024: $243 · 2025: $8,525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,505 · Food and Beverage: $1,452 · Travel and Lodging: $189 · Gift: $19.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,505.46 |
| Food and Beverage | $1,451.88 |
| Travel and Lodging | $189.33 |
| Gift | $19.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,145.88 | 2019-2025 | Da Vinci Surgical System |
| Astellas Pharma US INC | $582.51 | 2019-2023 | Myrbetriq |
| Janssen Biotech, INC. | $207.47 | 2019-2025 | Carvykti, Rybrevant |
| Endo Pharmaceuticals INC. | $176.55 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $162.19 | 2019-2023 | |
| Myriad Genetic Laboratories, INC. | $117.21 | 2022 | |
| Procept Biorobotics Corporation | $112.19 | 2022 | |
| Abbvie INC. | $103.69 | 2019-2024 | Lupron Depot |
| Urogen Pharma, INC. | $60.54 | 2022-2024 | Jelmyto |
| Amgen INC. | $58.55 | 2019 | |
| Pfizer INC. | $56.69 | 2019-2023 | |
| Travere Therapeutics, INC. | $45.69 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $29.69 | 2019 | |
| Ferring Pharmaceuticals INC. | $27.61 | 2019-2020 | |
| Progenics Pharmaceuticals, INC. | $23.95 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $19.96 | 2019 | |
| Boston Scientific Corporation | $18.33 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $18.11 | 2023 | Lynparza |
| Richard Wolf Medical Instruments Corp. | $13.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julien Dagenais listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.